State Secretary Blokhuis: boys will also be vaccinated against HPV virus
The vaccine against the HPV human papillomavirus virus will also become available for boys.
Antimicrobial resistance in the Netherlands is remaining reasonably stable
Antimicrobial resistance is increasing on a global level. It is difficult to treat infections caused by resistant bacteria.
Updated immunisation recommendation for measles: early vaccination before travel
A number of European countries are currently seeing outbreaks of measles. Before the start of the summer season, RIVM has therefore updated its immunisation recommendation for measles.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg
Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Research: HPV vaccine is safe
RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.
Vaccination rate again drops slightly, HPV vaccination rate drops considerably
The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.
Risk of measles outbreaks increases with decreasing vaccination coverage
Vaccination coverage for vaccinations in the Dutch National Vaccination Program (NIP) decreased slightly by about half a percent for the third consecutive year.
Measles epidemic and Salmonella outbreak cost nearly six million euros
The most recent measles epidemic and outbreak of Salmonella Thomson due to smoked salmon have cost 3.9 and 1.7 million euros, respectively.